Immunomodulatory activities of gemifloxacin in mice
Publish place: Iranian Journal of Basic Medical Sciences، Vol: 19، Issue: 9
Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 168
This Paper With 8 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-19-9_010
تاریخ نمایه سازی: 30 مهر 1400
Abstract:
Objective(s):Gemifloxacin is a broad spectrum antibiotic and has shown excellent coverage against a wide variety of microorganisms. In this study, an attempt was made to evaluate the immunomodulatory potential of gemifloxacin in male swiss albino mice in vivo. Materials and Methods: Three doses of gemifloxacin ۲۵ mg/kg, ۵۰ mg/kg and ۷۵ mg/kg were used intraperitoneally (IP) for the evaluation of immune responses in mice. Delayed type hypersensitivity (DTH), heamagglutination assay, jerne hemolytic plaque formation assay and cyclophosphamide induced neutropenia assay were performed to evaluate the effect of gemifloxacin on immune responses. Results: DTH assay has shown the significant immune suppressant potential of gemifloxacin at ۲۵ mg/kg dose and ۷۵mg/kg dose. Total leukocyte count (TLC) has shown decrease in leukocyte count (P<۰.۰۵) in drug treatment groups before cyclophosphamide administration and significant decrease (P<۰.۰۰۱) in leukocyte count after cyclophosphamide administration as compared to negative control group. Differential leukocyte count (DLC) has shown significant decrease (P<۰.۰۰۱) in percentage count of lymphocytes in ۷۵ mg/kg treatment group in leukopenic mice while increase (P<۰.۰۱) in monocytes percentage in ۵۰ mg/kg treatment group in leukopenic mice and increase in neutrophil percentage count (P<۰.۰۵) in all treatment groups was observed after cyclophosphamide administration. Humoral immune response is shown to be suppressed in dose dependent manner by both heamagglutination titre values (P<۰.۰۰۱) and jerne hemolytic plaque formation assay (P<۰.۰۰۱). Conclusion: The results of this work clearly demonstrate that gemifloxacin has significant immunomodulatory potential.
Keywords:
Authors
Muhammad Umair
Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences, Lahore, Pakistan
Aqeel Javeed
Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences, Lahore, Pakistan
Aamir Ghafoor
University Diagnostics Laboratory, University of Veterinary and Animal Sciences, Lahore, Pakistan
Muhammad Ashraf
Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences, Lahore, Pakistan
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :